Tuesday, Jul 17, 2018
engineered enzymes for better healthcare

Technology science-behind-research-and-development-200-small

Our NeoScreenPak methodology relies on highly specific and stable enzymes developed at University College Dublin and exclusively licensed to Enzolve Technologies. These enzymes allow single-step assays with colorimetric detection for each of the metabolites to be tested in a blood sample, for fast, easy, accurate and reproducible quantitation.

 

Technology.................... Advantages ........................Pipeline

 

.

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...